Follow
Luis Ulloa
Title
Cited by
Cited by
Year
Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation
H Wang, M Yu, M Ochani, CA Amella, M Tanovic, S Susarla, JH Li, ...
Nature 421 (6921), 384-388, 2003
38202003
Reversing established sepsis with antagonists of endogenous high-mobility group box 1
H Yang, M Ochani, J Li, X Qiang, M Tanovic, HE Harris, SM Susarla, ...
Proceedings of the National Academy of Sciences 101 (1), 296-301, 2004
14472004
Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis
H Wang, H Liao, M Ochani, M Justiniani, X Lin, L Yang, Y Al-Abed, ...
Nature medicine 10 (11), 1216-1221, 2004
13722004
Inhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/STAT pathway
L Ulloa, J Doody, J Massagué
Nature 397 (6721), 710-713, 1999
10851999
Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation
L Ulloa, M Ochani, H Yang, M Tanovic, D Halperin, R Yang, CJ Czura, ...
Proceedings of the National Academy of Sciences 99 (19), 12351-12356, 2002
7732002
Splenectomy inactivates the cholinergic anti-inflammatory pathway during lethal endotoxemia and polymicrobial sepsis
JM Huston, M Ochani, M Rosas-Ballina, H Liao, K Ochani, VA Pavlov, ...
Shock 25 (6), 65, 2006
7512006
The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation
WJ De Jonge, L Ulloa
British journal of pharmacology 151 (7), 915-929, 2007
7042007
Pharmacological stimulation of the cholinergic antiinflammatory pathway
TR Bernik, SG Friedman, M Ochani, R DiRaimo, L Ulloa, H Yang, ...
The Journal of experimental medicine 195 (6), 781-788, 2002
6902002
Dopamine mediates vagal modulation of the immune system by electroacupuncture
R Torres-Rosas, G Yehia, G Peña, P Mishra, ...
Nature medicine 20 (3), 291-295, 2014
5712014
The ‘cytokine profile’: a code for sepsis
L Ulloa, KJ Tracey
Trends in molecular medicine 11 (2), 56-63, 2005
5442005
The vagus nerve and the nicotinic anti-inflammatory pathway
L Ulloa
Nature reviews Drug discovery 4 (8), 673-684, 2005
5332005
Structural basis for the proinflammatory cytokine activity of high mobility group box 1
J Li, R Kokkola, S Tabibzadeh, R Yang, M Ochani, X Qiang, HE Harris, ...
Molecular medicine 9, 37-45, 2003
5302003
High-mobility group box 1 (HMGB1) protein: friend and foe
L Ulloa, D Messmer
Cytokine & growth factor reviews 17 (3), 189-201, 2006
4842006
The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice
DJ Van Westerloo, IA Giebelen, S Florquin, MJ Bruno, GJ LaRosa, L Ulloa, ...
Gastroenterology 130 (6), 1822-1830, 2006
4592006
High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis
R Kokkola, E Sundberg, AK Ulfgren, K Palmblad, J Li, H Wang, L Ulloa, ...
Arthritis & Rheumatism 46 (10), 2598-2603, 2002
3972002
α7-cholinergic receptor mediates vagal induction of splenic norepinephrine
G Vida, G Peña, EA Deitch, L Ulloa
The Journal of Immunology 186 (7), 4340-4346, 2011
2692011
Bacterial endotoxin stimulates macrophages to release HMGB1 partly through CD14-and TNF-dependent mechanisms
G Chen, J Li, M Ochani, B Rendon-Mitchell, X Qiang, S Susarla, L Ulloa, ...
Journal of leukocyte biology 76 (5), 994-1001, 2004
2662004
Hmgb-1 as a therapeutic target for infectious and inflammatory disorders
LL Mantell, WR Parrish, L Ulloa
Shock 25 (1), 4-11, 2006
2152006
Depletion of casein kinase II by antisense oligonucleotide prevents neuritogenesis in neuroblastoma cells.
L Ulloa, J Diaz‐Nido, J Avila
The EMBO journal 12 (4), 1633-1640, 1993
1971993
Recombinant HMGB1 with cytokine-stimulating activity
J Li, H Wang, JM Mason, J Levine, M Yu, L Ulloa, CJ Czura, KJ Tracey, ...
Journal of immunological methods 289 (1-2), 211-223, 2004
1852004
The system can't perform the operation now. Try again later.
Articles 1–20